Ocular Therapeutix initiates first phase III trial of OTX-TP for glaucoma and ocular hypertension Oct. 5, 2016 No Comments
Regeneron reports topline data from phase II trial of aflibercept/rinucumab in wet AMD Oct. 3, 2016 No Comments
RSS